There are 21 papers on HAS-BLED score in aging research: 1 trial and 18 observational studies in people, 1 review.
21 papers study it19 more mention it4 findings
3 new papers in 30 daysSee all 40 papers on HAS-BLED score
“HR 1.4 (95% CI: 1.3-1.5) for HAS-BLED 3+”
- Human trial1
- Humans18
Upstream
1Bleeding complications
no changein humans1
1 study
Bleeding complications
no changein humans1
Bleeding complications were not clearly linked with HAS-BLED score in humans (patients with versus without bleeding complications during direct oral anticoagulant use).
Humanspatients with versus without bleeding complications during direct oral anticoagulant usemean of 2.56 yearsn = 142
Associations
3Noncardiovascular frail events
upin humans1HR 1.4
1 study
Noncardiovascular frail events
upin humans1HR 1.4
HAS-BLED score is linked with a higher risk of noncardiovascular frail events in humans after adjusting for covariates in patients with AF (HR 1.4 (95% CI: 1.3-1.5)).
Humansafter adjusting for covariates in patients with AF
Frailty
upin humans1OR 13.4
1 study
Frailty
upin humans1OR 13.4
HAS-BLED score is associated with frailty in patients with AF (OR 13.4 (10.2-17.5)).
Humansin patients with AF
Intracerebral hemorrhage
upin humans1
1 study
Intracerebral hemorrhage
upin humans1
HAS-BLED score predicts intracerebral hemorrhage in humans (highest complexity level; HAS-BLED cut-off ≥3) (AUC 0.7).
Humanshighest complexity level; HAS-BLED cut-off ≥3five years